Investors Elicera Therapeutics Ab Jamal el mosleh, ceo of elicera therapeutics, presents at investing in life science from seed to success. about the event on september 12, 2024, biostock. 16 september, 2024. last week, investors and entrepreneurs gathered at the world trade center in stockholm for our “investing in life science: from seed to success” event co hosted by vator securities. the event brought together leaders in the life science industry to explore the critical stages of investment, from early seed funding to.
Elicera Therapeutics Life Sciencedagen Youtube Full speed ahead for elicera in 2024. elicera therapeutics has kicked off the year in boost mode. the swedish cell and gene therapy company will get moving on the newly approved phase i iia study with lead car t candidate elc 301, made possible by a major financing round coming later this month. speaking to elicera’s ceo jamal el mosleh, it. Elicera therapeutics' ceo jamal el mosleh presents the company at biostock life science summit in october 2023.0:00 introduction1:00 itank platform2:40 car t. Find the latest elicera therapeutics ab (publ) (elic.st) stock quote, history, news and other vital information to help you with your stock trading and investing. This collaboration will explore the potential of elc 201 across various solid tumour indications. biostock turned to elicera’s ceo jamal el mosleh to learn more. as made evident in elicera therapeutics’ q1 report, the swedish gene therapy company is advancing steadily with its car t project, elc 301. clinical evaluation of the candidate is.
Comments are closed.